home · filing · 0001193125-23-005019
8-K filed January 10, 2023, 6:59 PM ET
ticker RGNX
CIK 0001590877
leadership
confidence high
sentiment neutral
materiality 0.60
REGENXBIO promotes Curran Simpson to COO, Shiva Fritsch to Chief Communications Officer
REGENXBIO Inc.
Curran Simpson appointed COO effective Jan 9, 2023; previously SVP, Chief Technology and Operations Officer since 2015.
Shiva Fritsch elevated to Chief Communications Officer while retaining Chief People Officer role; joined REGENXBIO in 2017.
Promotions follow opening of Manufacturing Innovation Center and progress toward '5 x '25' strategy for five AAV therapeutics.
Simpson will oversee manufacturing, quality, regulatory, preclinical development, and corporate strategy.
Fritsch will oversee internal/external communications and human resources.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Role change
Curran M. Simpson
Chief Operating Officer
Effective 2023-01-09
Filed January 10, 2023, 6:59 PM ET
On January 9, 2023, REGENXBIO Inc. (the “Company”) announced that Curran M. Simpson has been named Chief Operating Officer, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Curran M. Simpson was named as Chief Operating Officer at REGENXBIO Inc..
Action named
Role Chief Operating Officer
Exact text from the filing
On January 9, 2023, REGENXBIO Inc. (the “Company”) announced that Curran M. Simpson has been named Chief Operating Officer, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-23-005019
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.